Donald Trump knocked yet another industry in his press conference Wednesday, but this time it wasn’t manufacturers or car makers. It was health care. And shares of U.S. pharmaceutical companies promptly fell, dropping by an average range of about 3% to 5%. “We’ve got to get our drug industry back,”
This post was published on ZYX Buy Change Alert. Initiate or add in the zone of $13.50 to $14.52. Suitable only for aggressive investors More later as it is moving fast. COMMENT $LABD $IBB $XBI $PJP $PPH $XPH $IHE $BMY $MRK As a full disclosure, paying subscribers to ZYX Buy Change Alert
The first presidential debate between Hillary Clinton and Donald Trump is scheduled for Sept. 26. The secret to success in investing and trading is to prepare for various scenarios in advance, in this case, the debate. Let us start by looking at key S&P 500 — represented by the SPDR
This post was just published on ZYX Buy Change Alert. BPMC is long from $19.20. As of this writing it is trading at $31.59. Profits have been taken as high as $32.73. 30% of the full core position size is being held. Consider protective stops, 10% tranche each in the following
This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide
This post was just published on ZYX Buy Change Alert. BPMC is a recent biotech IPO that was bought in the after market at an average price of $19.20. As of this writing it is trading at $29.20. 40% of the full core position size is being held. Consider taking profits on a
This post was just published on ZYX Buy Change Alert. In view of overall market conditions, especially the negative money flow in biotechs, consider accumulating a maximum of 40% of BPMC. Previous call was to accumulate up to 60%. Please adjust the quantity based on your own risk tolerance. You are
This post was just published on ZYX Buy Change Alert. BPMC is a biotech firm focused on developing cancer treatment therapies. This is a new IPO. It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high. Here is the plan: Consider buying
This post was just published on ZYX Global Multi Asset Allocation Alert. The stock market in the United States is throwing a tantrum. Let us examine stock market’s concerns and how our model portfolios are positioned. Euro Is Falling The best way to profit from the falling euro is short the currency and
Full video: http://www.spreecast.com/events/trading-stategies-for-april-2014 Investments to avoid http://www.spreecast.com/events/trading-stategies-for-april-2014/clips/investments-to-avoid Where should investors turn? http://www.spreecast.com/events/trading-stategies-for-april-2014/clips/where-should-investors-turn Outlook on technology http://www.spreecast.com/events/trading-stategies-for-april-2014/clips/outlook-on-technology What should investors do if Russia invades Ukraine? http://www.spreecast.com/events/trading-stategies-for-april-2014/clips/what-should-investors-do-if-russia-invades-ukraine How should investors play the energy sector? http://www.spreecast.com/events/trading-stategies-for-april-2014/clips/how-should-investors-play-the-energy-sector-right-now Final thoughts http://www.spreecast.com/events/trading-stategies-for-april-2014/clips/final-thoughts